Effects of Strength Training Combined With Sustainable Source of Omega-3 Fatty Acids on Muscle Strength and Cognitive Functions in Adults Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of the study is to evaluate the effects of 12-week supplementation with algae-derived DHA combined with strength training on muscle strength, neuromuscular parameters, post-exercise inflammation and cognitive functions in healthy adults compared to fish-derived EPA and DHA combined with strength training, strength training alone and control group. The research methods and measurement tools include:
- Body composition assessed prior to the training intervention and after 12 weeks of training: body mass index (BMI) and body composition - fat mass \[kg\], body fat percentage \[%\] and skeletal muscle mass \[kg\] - will be determined using bioimpedance methods (In Body 720, Biospace, Seoul, Korea) following an overnight fast.
- Assessment of physical activity levels using the long version of the International Physical Activity Questionnaire (IPAQ).
- Assessment of mood (UMACL Adjective Mood Scale) and depression (DASS-21, Beck Depression Scale).
- The SarQoL (Sarcopenia and Quality of Life) questionnaire, used to specifically assess quality of life in people with reduced muscle mass and function.
- Assessment of participants' diet: each participant will be required to record their diet in 3-day food diaries (to be checked on the first day of testing).
- Blood sampling: blood will be collected from each participant at two time points before and after the intervention (on an empty stomach, and 40 minutes after the training session). The following will be collected: 1 × 6 ml blood count tube and 3 tubes with a clotting activator, with a total volume of 20 ml. Blood will be collected before the start of the training intervention and after 12 weeks of training. The tubes will be centrifuged at 4 °C (4000 × g for 10 minutes). The serum, plasma and erythrocyte fractions will then be frozen at -80 °C until analysis.
- Peak force, relative peak force and force at 150, 200 and 250 milliseconds during isometric mid-thigh pull-ups using a Kistler platform (Kistler dynamometer platform, model 9286BA, with MARS software). The maximum load (1RM) will also be measured for each participant. Upper limb grip strength will be measured using a SAEHAN electronic dynamometer.
- In addition, muscle electrical activity using a Noraxon Telemyo surface electromyograph will be assessed.
- Cognitive function will be assessed using the following tests: the Stroop Test, the Corsi Block-Tapping Task and the Pattern Separation Task. All analysis (beside IPAQ) will be performed before and after 12 weeks of intervention.
- During the study, all participants will take part in a strength training session (around 40 mins duration) led by an experienced trainer to stimulate the muscles to release myokines.
- Blood tests will include: BDNF, IGF-1, IL-6, hs-CRP, TNF-alpha, and IL-1B as well as concentrations of metabolites of the kynurenine pathway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedStudy Start
First participant enrolled
August 23, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
Study Completion
Last participant's last visit for all outcomes
January 1, 2030
August 13, 2026
August 1, 2026
2.4 years
July 13, 2026
August 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peak force (N), relative peak force (N/kg bw) and force at 150, 200, and 250 milliseconds (N) during Isometric Mid-Thigh Pull (IMTP) and Back Squat
12 weeks intervention
Study Arms (6)
algae-derived DHA + strength training
EXPERIMENTAL3g of a algae-derived DHA + strength training 3 times a week through 12 weeks
fish-derived omega-3 + strength training
EXPERIMENTAL3g of a fish-derived omega-3 (EPA+DHA) + strength training 3 times a week through 12 weeks
placebo + strength training
PLACEBO COMPARATOR3g of a placebo + strength training 3 times a week through 12 weeks
algae-derived DHA without strength training
ACTIVE COMPARATOR3g of a algae-derived DHA through 12 weeks
fish-derived omega-3 without strength training
ACTIVE COMPARATOR3g of a fish-derived omega-3 (EPA+DHA) through 12 weeks
placebo without strength training
PLACEBO COMPARATOR3g of a placebo through 12 weeks
Interventions
Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with 3g/per day DHA from algae supplementation. The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with EPA and DHA from fish supplementation (3g per day). The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with placebo supplementation. The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Healthy, untrained men and women will participate in a 12-week DHA from algae supplementation (3g per day). At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Healthy, untrained men and women will participate in a 12-week EPA and DHA from fish supplementation (3g per day). At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Healthy, untrained men and women will participate in a 12-week placebo supplementation. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.
Eligibility Criteria
You may qualify if:
- years of strength training experience,
- without chronic or autoimmune diseases,
- between the ages of 25 and 35,
- not obese,
- not taking omega-3 fatty acids,
- not taking protein, BCAAs, creatine, anabolic steroids, or other supplements
- for women: not pregnant or breastfeeding, and at least 1 year after childbirth (to allow for hormonal balance to stabilize).
- For the control group (non-exercisers):
- \- Requirements as above, except for exercise: we recruit individuals who exercise less than 1 hour per week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Physical Education and Sport
Gdansk, Poland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- A double-blind design will be employed. An independent researcher external to the research team will perform the randomization via www.randomizer.org. Based on the allocation list, this individual will distribute the omega-3 fatty acid capsules and placebos into identical bottles. Consequently, both the investigators and the participants will remain blinded to whether the active supplement or placebo is being administered.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2026
First Posted
August 13, 2026
Study Start (Estimated)
August 23, 2026
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2030
Last Updated
August 13, 2026
Record last verified: 2026-08